Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Moodys
Teva
Chubb
Cantor Fitzgerald
Express Scripts
Covington
Argus Health
Deloitte
Novartis

Generated: October 21, 2017

DrugPatentWatch Database Preview

Amitriptyline hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for amitriptyline hydrochloride and what is the scope of amitriptyline hydrochloride freedom to operate?

Amitriptyline hydrochloride
is the generic ingredient in eighteen branded drugs marketed by Par Pharm, Roxane, Astrazeneca, Roche, Purepac Pharm, Mylan, Teva, Watson Labs, Sun Pharm Inds Inc, Vangard, Vintage Pharms, Copley Pharm, Halsey, Mutual Pharm, Ani Pharms Inc, Ucb Inc, Warner Chilcott, Lederle, Accord Hlthcare, West Ward, Superpharm, Bristol Myers Squibb, Sandoz, Am Therap, Usl Pharma, Pliva, Zydus Pharms Usa Inc, Heritage Pharms Inc, Watson Labs Teva, Anda Repository, Mylan Pharms Inc, Schering, New River, Ivax Sub Teva Pharms, and Sun Pharm Inds, and is included in one hundred and seventy-seven NDAs. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for amitriptyline hydrochloride. Forty-three suppliers are listed for this compound.

Summary for Generic Name: amitriptyline hydrochloride

US Patents:0
Tradenames:18
Applicants:35
NDAs:177
Drug Master File Entries: see list13
Suppliers / Packagers: see list43
Bulk Api Vendors: see list61
Clinical Trials: see list2,358
Patent Applications: see list2,761
Therapeutic Class:Antidepressants
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:amitriptyline hydrochloride at DailyMed

Pharmacology for Ingredient: amitriptyline hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz
AMITRIPTYLINE HYDROCHLORIDE
amitriptyline hydrochloride
TABLET;ORAL085971-001Approved Prior to Jan 1, 1982ABRXNoNo► Subscribe► Subscribe► Subscribe
Lederle
AMITRIPTYLINE HYDROCHLORIDE
amitriptyline hydrochloride
TABLET;ORAL087367-001May 3, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Roche
ENDEP
amitriptyline hydrochloride
TABLET;ORAL083639-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Mutual Pharm
AMITRIPTYLINE HYDROCHLORIDE
amitriptyline hydrochloride
TABLET;ORAL085742-002May 11, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE
amitriptyline hydrochloride; perphenazine
TABLET;ORAL071558-001Mar 2, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva
AMITRIPTYLINE HYDROCHLORIDE
amitriptyline hydrochloride
TABLET;ORAL086860-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan
PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE
amitriptyline hydrochloride; perphenazine
TABLET;ORAL071443-003Nov 10, 1988RXNoNo► Subscribe► Subscribe► Subscribe
Lederle
AMITRIPTYLINE HYDROCHLORIDE
amitriptyline hydrochloride
TABLET;ORAL086745-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Mutual Pharm
AMITRIPTYLINE HYDROCHLORIDE
amitriptyline hydrochloride
TABLET;ORAL085744-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Par Pharm
AMITRIPTYLINE HYDROCHLORIDE
amitriptyline hydrochloride
TABLET;ORAL088702-001Sep 25, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: amitriptyline hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca
ELAVIL
amitriptyline hydrochloride
TABLET;ORAL012703-006Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Astrazeneca
ELAVIL
amitriptyline hydrochloride
TABLET;ORAL012703-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Astrazeneca
ELAVIL
amitriptyline hydrochloride
TABLET;ORAL012703-004Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Astrazeneca
ELAVIL
amitriptyline hydrochloride
TABLET;ORAL012703-005Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Astrazeneca
ELAVIL
amitriptyline hydrochloride
TABLET;ORAL012703-007Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Astrazeneca
ELAVIL
amitriptyline hydrochloride
TABLET;ORAL012703-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Astrazeneca
ELAVIL
amitriptyline hydrochloride
INJECTABLE;INJECTION012704-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Novartis
Chinese Patent Office
Fish and Richardson
Merck
Chubb
Deloitte
UBS
Johnson and Johnson
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot